Location: Home
  • search
  • go
  • Relate News
  • 12/4/2023Novartis to Invest CNY 600M for Second Production Site in Zhejiang
  • 12/4/2023Tang Capital's Concentra Bio Makes Unsolicited Bid for LianBio
  • 12/4/2023Harbour Biomed Withdraws NDA for Batoclimab (HBM9161) in China
  • 12/4/2023Aspen Pharma Makes Further Inroads into China by Taking Over Sandoz Ch...
  • 12/4/2023USFDA Investigates Quality Issues with Chinese-made Plastic Syringes
  • 12/3/2023Navigating Another New Normal in China as De-risking Starts to Bite Pr...
  • 12/1/2023China Forms National Coordination Network to Combat Thalassemia
  • 12/1/2023CDE Issues the Technical Guidelines for Clinical Safety Evaluation of ...
  • 12/1/2023CDE Issues the Technical Requirements for Generic Pharma Research of F...
  • 12/1/2023CDE Issues the Technical Guidelines for Clinical Trials of Atopic Derm...
  • 12/1/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 11/30/2023Recent Official and Executive Moves
  • 11/30/2023Drug R&D and Product Registration News Digest 11/2023 (3)
  • 11/30/2023Financial-related Company News Digest (November 2023)
  • 11/30/2023China's Evolving Role in CAR-T Therapy: Navigating Global Alliances an...
  • 11/28/2023CDE Solicits Comments on the Guidelines for the Acceptance and Review ...
  • 11/28/2023Evommune and Accutar Biotech Announce AI Drug Discovery Collaboration
  • 11/28/2023India's Dependence on Chinese APIs Reduced to Some Extent after PLI Sc...
  • 11/28/2023Takeda China Expands Collaborations for Digital Healthcare Innovation ...
  • 11/27/2023CDE Solicits Comments on the Technical Guidelines for Application of D...
  • 11/27/2023AstraZeneca to open Hong Kong R&D centre by late 2024 at earliest with...
  • 11/27/2023Coherus Sets Price of China-Made PD-1 Inhibitor Loqtorzi at a 20% Disc...
  • 11/27/2023Indian Pharma to Benefit amid Big Pharma's China De-Risking
  • 11/27/2023Over 1B Enrollees Signed Up BMI's Digital Code System Four Year After ...
  • 11/27/2023China's BMI Fund Tops CNY 2.6T in Revenue in First Ten Months of 202...
  • 11/27/2023Moderna Begins Work on Its mRNA China Plant
  • 11/27/2023CDE Solicits Comments on the Detailed Rules on Adding Pediatric Inform...
  • 11/26/2023Zhifei to Acquire Chenan to Expand into Metabolic Disease Drugs
  • 11/26/2023Dizal Strikes Derma Drug JV Deal with Wuxi High-tech Zone
  • 11/26/2023NHSA Issues New Doc to Strengthen and Enhance Drug Price and Tender Cr...
  • Page:25/718 Total number of articles:21536: [First][<<] [23] [24] [25] [26] [27] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group